Cadrenal Therapeutics (CVKD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist

15.820
-0.500-3.06%

Trading Nov 19 11:00 ET

26.24MMarket Cap-2567P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
PR NewswireNov 19 09:00 ET
Cadrenal Therapeutics Files to Sell 590K Shares of Common Stock for Holders
TipRanksNov 14 16:11 ET
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Yahoo FinanceNov 12 09:00 ET
Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesNov 11 13:06 ET · Ratings
H.C. Wainwright Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Cuts Target Price to $32
Moomoo NewsNov 8 10:31 ET · Ratings
Express News | Cadrenal Therapeutics Inc : H.c. Wainwright Adjusts Target Price to $32 From $3 to Reflect 1-for-15 Reverse Stock Split
ReutersNov 8 09:52 ET

Comments

Stock_Drift

Sep 23 15:48

$Cadrenal Therapeutics (CVKD.US)$

Stock_Drift

Sep 17 17:23

$Cadrenal Therapeutics (CVKD.US)$

Stock_Drift

Sep 13 14:27

$Cadrenal Therapeutics (CVKD.US)$

Jaguar8

Aug 20 08:42

NEWS

$Cadrenal Therapeutics (CVKD.US)$
Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
Cadrenal Therapeutics (Nasdaq: CVKD) highlighted a recently published manuscript in the Journal of Cardiac Failure, evaluating the relationship between time in therapeutic range (TTR) management quality and clinical outcomes for left ventricular assist device (LVAD) patients. The findings emphasize the need for improved anticoagulation th...